Search

637 results
Home > Resources > Publications

Use this form to apply for the surrender of a low- or high-level containment facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000.

Home > Resources > Publications

Use this form to apply for the variation of a facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000 and, as applicable, corresponding state legislation.

Home > Resources > Publications

Details of OGTR monitoring and compliance activities during the quarter ended 31 March 2024.

Home > Resources > Publications

This Communiqué covers matters considered at the 59th meeting of the Gene Technology Technical Advisory Committee (4 March 2024).

Home > Resources > Publications

This issue focuses on the PC2 Guidelines and the OGTR Online Services Portal.

Home > Resources > Publications

Use this form to notify the OGTR of commencement or completion of minor works to PC1 or PC2 certified facilities.

Home > Resources > Publications

This document describes how the potential risks of RNAi technology (gene silencing) are considered when preparing Risk Assessment and Risk Management Plans (RARMPs).

Home > Resources > Publications

This document describes how the potential risks of plant genetic modification (plant transformation) are considered when preparing Risk Assessment and Risk Management Plans (RARMPs).

Home > Resources > Publications

Glowing or fluorescent fish such as GloFish® are genetically modified organisms (GMOs) and it is illegal to import them into Australia for personal or commercial use without an authorisation from the Regulator.

Home > Resources > Publications

In 2014 the Gene Technology Regulator (the Regulator) approved a trial of an oral live genetically modified cholera vaccine. Up to 1000 people were given a dose of the vaccine in a drink.